Detalhe da pesquisa
1.
A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment.
J Formos Med Assoc
; 123(1): 55-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666718
2.
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Sci Rep
; 10(1): 5372, 2020 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32214132
3.
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.
PLoS One
; 10(9): e0137852, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368130